Your browser doesn't support javascript.
loading
Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).
Liu, Albert Y; Norwood, Aliza; Gundacker, Holly; Carballo-Diéguez, Alex; Johnson, Sherri; Patterson, Karen; Bekker, Linda-Gail; Chariyalertsak, Suwat; Chitwarakorn, Anupong; Gonzales, Pedro; Holtz, Timothy H; Mayer, Kenneth H; Zorrilla, Carmen; Buchbinder, Susan; Piper, Jeanna M; Lama, Javier R; Cranston, Ross D.
Afiliação
  • Liu AY; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA.
  • Norwood A; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA.
  • Gundacker H; Departments of Population Health and Internal Medicine, University of Texas at Austin, Austin, TX.
  • Carballo-Diéguez A; Statistical Center for HIV/AIDS Research and Prevention/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Johnson S; Department of Psychiatry, New York State Psychiatric Institute and Columbia University, New York City, NY.
  • Patterson K; FHI 360, Durham, NC.
  • Bekker LG; Statistical Center for HIV/AIDS Research and Prevention/Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Chariyalertsak S; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Chitwarakorn A; Department of Community Medicine, Research Institute for Health Sciences (RIHES), Chiang Mai University, Chiang Mai, Thailand.
  • Gonzales P; Thailand Ministry of Public Health, Nonthaburi, Thailand.
  • Holtz TH; Asociacion Civil Impacta Salud y Educacion, San Miguel, Peru.
  • Mayer KH; Thailand Ministry of Public Health-US CDC Collaboration, Nonthaburi, Thailand.
  • Zorrilla C; Department of HIV/AIDS Prevention, CDC, Atlanta, GA.
  • Buchbinder S; Fenway Health, The Fenway Institute, Boston, MA.
  • Piper JM; Department of Obstetrics and Gynecology, CEMI/UPR-CTU, University of Puerto Rico, San Juan, Puerto Rico.
  • Lama JR; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA.
  • Cranston RD; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
J Acquir Immune Defic Syndr ; 81(5): 516-520, 2019 08 15.
Article em En | MEDLINE | ID: mdl-31299013
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Tenofovir Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição / Tenofovir Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article